Uremia induces adipose tissue inflammation and muscle mitochondrial dysfunction

Area of Science:

• Nephrology
• Cell Biology
• Immunology

Background:

• End-stage renal disease (ESRD) is characterized by systemic inflammation and elevated reactive oxygen species (ROS).
• These factors contribute to various ESRD complications.
• The interplay between inflammation, oxidative stress, and tissue dysfunction in ESRD requires further elucidation.

Purpose of the Study:

• To investigate the histological features of adipose tissue in ESRD.
• To assess muscle mitochondrial function in uremia.
• To determine the relationship between inflammation and these changes in ESRD.

Main Methods:

• Histological analysis (immunohistochemistry, Western blot) of adipose and muscle tissues from ESRD patients and controls.
• In vitro uremic muscle cell model (C2C12 cells) exposed to uremic serum and inflammatory cytokines.
• Mitochondrial function assessment using MitoTracker Orange, TOMM20 expression, and oxidative phosphorylation complex subunit analysis.

Main Results:

• ESRD patients exhibited increased macrophage infiltration in adipose tissue compared to controls.
• Muscle tissue in ESRD patients showed reduced TOMM20 expression, indicating impaired mitochondrial function.
• In vitro models confirmed that uremia and inflammatory cytokines (TNF-α, IL-6) induce mitochondrial dysfunction, which can be partially reversed by N-acetyl cysteine and adiponectin.

Conclusions:

• Uremia is linked to increased adipose tissue macrophage infiltration and muscle mitochondrial dysfunction driven by inflammation and ROS.
• Adipose tissue acts as a significant inflammatory source in ESRD, independent of adiposity.
• This inflammation contributes to mitochondrial dysfunction observed in uremic conditions.